share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Jul 11 04:45
Summary by Futu AI
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 07/10/2024, with an aggregate market value of $108,575.69. The shares were acquired through stock option exercises on 06/13/2023 and 06/14/2023, with a total of 15,000 shares obtained from the issuer for a cash payment. This planned sale follows a series of transactions over the past three months, where a total of 93,124 shares were sold for gross proceeds of approximately $755,664.65.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 07/10/2024, with an aggregate market value of $108,575.69. The shares were acquired through stock option exercises on 06/13/2023 and 06/14/2023, with a total of 15,000 shares obtained from the issuer for a cash payment. This planned sale follows a series of transactions over the past three months, where a total of 93,124 shares were sold for gross proceeds of approximately $755,664.65.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.